Correlation Between Novartis and Alcon AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novartis and Alcon AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Alcon AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG and Alcon AG, you can compare the effects of market volatilities on Novartis and Alcon AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Alcon AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Alcon AG.

Diversification Opportunities for Novartis and Alcon AG

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novartis and Alcon is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Alcon AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alcon AG and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Alcon AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alcon AG has no effect on the direction of Novartis i.e., Novartis and Alcon AG go up and down completely randomly.

Pair Corralation between Novartis and Alcon AG

Assuming the 90 days trading horizon Novartis is expected to generate 1.51 times less return on investment than Alcon AG. In addition to that, Novartis is 1.16 times more volatile than Alcon AG. It trades about 0.08 of its total potential returns per unit of risk. Alcon AG is currently generating about 0.14 per unit of volatility. If you would invest  7,560  in Alcon AG on November 19, 2024 and sell it today you would earn a total of  568.00  from holding Alcon AG or generate 7.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Novartis AG  vs.  Alcon AG

 Performance 
       Timeline  
Novartis AG 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novartis AG are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Novartis is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Alcon AG 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alcon AG are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal fundamental indicators, Alcon AG may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Novartis and Alcon AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novartis and Alcon AG

The main advantage of trading using opposite Novartis and Alcon AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Alcon AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alcon AG will offset losses from the drop in Alcon AG's long position.
The idea behind Novartis AG and Alcon AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing